BioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024

Yahoo FinanceMar 20 19:00

BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study

Yahoo FinanceMar 12 19:00

BioCardia Reports Positive Interim Results From Phase III CardiAMP Cell Therapy Heart Failure Trial, With Compelling Data in Subgroup With Elevated NTproBNP Biomarker for Heart Failure

Yahoo FinanceMar 4 21:00

BioCardia (NASDAQ:BCDAW) Trading 17.1% Higher

BioCardia, Inc. (NASDAQ:BCDAW – Get Rating)'s stock price traded up 17.1% during trading on Tuesday . The stock traded as high as $1.01 and last traded at $0.88. 1,309 shares changed hands during mid-

Defense WorldApr 5, 2023 15:02

BioCardia (NASDAQ:BCDAW) Shares Down 28.9%

BioCardia, Inc. (NASDAQ:BCDAW – Get Rating) shares traded down 28.9% on Friday . The company traded as low as $0.74 and last traded at $1.01. 13,539 shares traded hands during mid-day trading, an incr

Defense WorldMar 11, 2023 16:26

BioCardia (NASDAQ:BCDAW) Trading Up 9.9%

BioCardia, Inc. (NASDAQ:BCDAW – Get Rating) was up 9.9% during mid-day trading on Wednesday . The company traded as high as $0.85 and last traded at $0.80. Approximately 905 shares traded hands during

Defense WorldFeb 16, 2023 15:51